BridgeBio Pharma EPS Basic from Tax Loss Carryforward (Quarterly) Insights

BridgeBio Pharma, Inc. (BBIO)

68.31 +0.40 (+0.59%) USD | NASDAQ | Feb 24, 16:00

70.00 +1.69 (+2.47%) After-Hours: 07:13

View EPS Basic from Tax Loss Carryforward (Quarterly) for BBIO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Tax Loss Carryforward (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	--
Mirum Pharmaceuticals, Inc.	--
Cogent Biosciences, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Sarepta Therapeutics, Inc.	--